Clinical Trial Update: The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score [Phase 3]

View source ↗

Summary

Phase 3 randomized, placebo-controlled trial evaluating the efficacy, onset of effect, and safety of Alfuzosin once daily for lower urinary tract symptoms due t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED